NDRA Stock Analysis: Buy, Sell, or Hold?
NDRA - ENDRA Life Sciences Inc. Common Stock
$6.20
0.89 (16.76%)
▲
5d:
+32.2%
30d:
+13.55%
90d:
+79.19%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When NDRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NDRA is 11.7% above its trading range ($5.55). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NDRA is 11.7% above its trading range ($5.55). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NDRA is currently trading at $6.20, which is considered extended relative to its 30-day fair value range of $4.54 to $5.55.
Technical Outlook: Technically, NDRA is in a uptrend. The price is approaching resistance at $5.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 16.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+370.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NDRA is in a uptrend. The price is approaching resistance at $5.98. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 16.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+370.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.54 -
$5.55
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price significantly overextended (+11.7% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+16.8%)
- BULLISH: Trading 370.8% below Wall St target ($25.00)
Trading Range Analysis
30-Day Trading Range
$4.54 -
$5.55
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.21
Resistance Level
$5.98
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.75
Wall Street Target
$25.00
(+370.8%)
Share & Embed Analysis
Last updated: June 24, 2026 11:04 AM ET
Data refreshes hourly during market hours. Next update: 12:04 PM
Data refreshes hourly during market hours. Next update: 12:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NDRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 59 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 63 BUY |
